The number of axillary nodes removed as a predictor of regional recurrence in node negative breast cancer

Radiotherapy and Oncology

Volumn 91, Issue 1, 2009, Pages 38-41

  Vujovic, Olga ^a   Yu, Edward ^a   Cherian, Anil ^a   Dar, A Rashid ^a   Stitt, Larry ^a   Perera, Francisco ^a  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Axillary nodes; Breast cancer; Regional recurrence

Indexed keywords

TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE INTERVAL; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIATION DOSE; SENTINEL LYMPH NODE; TUMOR VOLUME;

ADULT; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 62549086052     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.05.003     Document Type: Article

References (18)

1. Fisher B., Redmond C., Fisher E.R., et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312 (1985) 674-681
2. Delouche G., Bachelot F., Premont M., and Kurtz J.M. Conservative treatment of early breast cancer: long-term results and complications. Int J Radiat Oncol Biol Phys 13 (1987) 29-34
3. Recht A., Pierce S.M., Abner A., et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9 (1991) 988-996
4. Weaver D.L., Krag D.N., Ashikaga T., Harlow S.P., and O'Connell M. Pathologic analysis of sentinel and non-sentinel lymph nodes in breast cancer. Cancer 88 (2000) 1099-1107
5. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 (2003) 546-553
6. Cohen L.F., Breshin T.M., Kuerer H.M., Ross M.I., Hunt K.K., and Sahin A.A. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Path 24 (2000) 1266-1272
7. AJCC Cancer staging handbook, 6th ed. New York: Springer-Verlag; 2002. p. 263-4.
8. Bloom H.J.G., and Richardson W.W. Histological grading and prognosis in breast cancer. Br J Cancer 11 (1957) 359-377
9. Lee E.T., and Wang J.W. Statistical methods for survival data analysis. 3rd ed. (2003), John Wiley & Sons, New York
10. Vujovic O., Yu E., Cherian A., Dar A.R., Stitt L., and Perera F. Eleven-year follow-up results in the delay of breast irradiation after conservative breast surgery in node-negative breast cancer patients. Int J Radiat Oncol Biol Phys 64 (2006) 760-764
11. Fisher B., Redmond C., Poisson R., et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without radiation in the treatment of breast cancer. N Engl J Med 320 (1989) 822-828
12. Orr R.K. The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg Oncol 6 (1999) 109-116
13. de Boer R., Millen H.F.P., Roumen R.M.H., Rutten H.J.T., vander Sangen M.J.C., and Voogd A.C. Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer. Br J Surg 88 (2001) 118-122
14. Giuliano A.E., Kirgan D.M., Guenther J.M., and Morton D.L. Lympathic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-401
15. Veronesi U., Paganelli G., Viale G., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
16. Giuliano A.E., Haigh P.I., Brennan M.B., et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18 (2000) 2553-2559
17. Moore A. Breast-cancer therapy-looking back to the future. N Engl J Med 357 (2007) 1547-1549
18. Gans S., Magarey C., Schwartz P., Papadatos G., Graham P., and Vallentine J. Women's choice between sentinel lymph node biopsy and axillary clearance. Aust NZ J Surg 72 (2002) 110-113